Saturday 17 October 2026
Export CABR’s income statement to Excel — free account
Caring Brands, Inc.
CABR Healthcare Drug Manufacturers Specialty & Generic
Caring Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4,200.00, up 740.0% from fiscal 2024. In the quarter to June 2026, EPS fell 102.0% and free cash flow fell 121.3%, each against the same quarter a year earlier.
1.22
0.07
−5.43%
Follow CABR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 |
+4 more quarters Free account |
P/S ratio |
— | — | 2,777.62 | 0.00 | |
P/FCF ratio |
— | — | 0.00 | 0.00 | |
P/Operating CF |
— | — | (11.00) | (61.69) | |
P/B ratio |
— | — | 5.58 | 4.29 | |
Price to Tangible BV |
— | — | 0.00 | 0.00 | |
EV/Sales |
— | — | 2,270.35 | 0.00 | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | (5.63) | (12.32) | |
EV/FCF |
— | — | (5.63) | (12.32) | |
Quick Ratio |
4.73 | 5.29 | 12.38 | 0.03 | |
Current Ratio |
4.97 | 5.65 | 13.16 | 0.08 | |
Net Debt/EBITDA |
2.85 | 1.29 | 0.58 | 0.02 | |
Debt/Assets |
0.00% | 0.00% | 2.52% | 0.06% | |
Debt/Equity |
0.00 | 0.00 | 0.03 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.50 | 0.14 | 0.26 | 0.18 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
— | (6.00) | 6,227.67 | (51.79) | |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | (225,925.00%) | 142,842.86% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.83 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 309,675.00% | 0.00% | |
Graham Net Nets |
— | — | 0.18 | (0.05) | |
Graham Number |
— | — | 0.00 | 0.00 | |
Earnings Yield |
— | — | (53.52%) | (26.04%) | |
Free Cash Flow Yield |
— | — | (14.51%) | (8.11%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.05) | (0.04) | (0.08) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.05) | (0.04) | (0.08) | (0.01) | |
Cash per Share |
0.20 | 0.14 | 0.16 | 0.00 | |
Shareholders Equity per Share |
(0.30) | (0.14) | 0.15 | 0.19 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.30) | (0.14) | 0.15 | 0.19 | |
Free Cash Flow |
(0.46) | (0.55) | (1.06) | (0.18) | |
Working Capital |
1.53 | 1.79 | 2.15 | (0.52) | |
Net Current Asset Value |
(2.71) | (2.00) | 2.09 | (0.53) | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
0.23 | — | — | — | |
Average Inventory |
0.01 | — | — | — | |
Average Assets |
0.95 | 1.09 | 1.16 | 1.59 | |
Average Common Equity |
0.49 | — | — | — |
Columns are period end dates